옵션 체인은 다양한 행사가격과 만기일에 대한 Nano X Imaging의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Nano X Imaging에 대한 시장 심리를 평가합니다..

Nano X Imaging (NASDAQ:NNOX) 주식, 옵션 체인

Nano X Imaging

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.

News

APLD

NNOX

NVDA

RXRX

SERV

SOUN

어플라이드 디지털(NASDAQ:APLD)의 주식은 금요일 5% 이상 상승 마감했는데, 이는 엔비디아(NASDAQ:NVDA)가 해당 주식에 노출되었기 때문이다. 이후 시간외 거래에서 3% 이상 추가 상승했다.

엔비디아가 어플라이드 디지털의 3.6% 지분을 공개, 어플라이드 주가 급등

Nano X Imaging Ltd

Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) may have bright days thanks to theme parks and streaming, according to Rosenblatt&#8217;s Barton Crockett.
The Disney Analyst: Crockett maintains a Buy rating on Disney and raised the price target from $122 to $135.
The Analyst Takeaways: Disney's growth looks "do-able" and the stock is "buyable," Crockett writes in a new investor note.
Read Also: <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">Disney Q4 Earnings: Revenue And Profit Beat, Best Film Studio Performance, 3-Year Outlook And More</a>
The new $135 price target assumes Disney shares can trade closer to a forward price-to-earnings ratio of 22x, instead of the near 10% discount to the market average Disney stock has traded at in recent history.
"A northward re-rating for Disney can be supported by rising confidence in portfolio durability and growth trajectory, and less concern about exposure to secular pressures on linear TV and competition in streaming," Crockett said.
Disney's confidence in high single-digit earnings per share growth in 2025, and double-digit growth in 2026 and 2027 appears aggressive, Crockett says. But it could become a reality, he adds, after hearing more details from new CFO Hugh Johnson last week.
Disney remains focused on its theme park segment<a href="https://www.benzinga.com/markets/equities/24/12/42382381/disney-doubles-down-on-cruises-with-seven-new-ships-by-2031-targets-asian-market-expansion-best-time-to-invest-in-this-business"> and cruise lines</a>, which will continue to attract guests in future.
Disney's DTC segment, which includes Hulu, Disney+ and ESPN streaming platforms, could also be a key growth element, Crockett said.
The analyst said cross-promotion reduced churn and Disney+ is enjoying a lift in subscribers thanks to several hit films. <a href="https://www.benzinga.com/general/entertainment/24/11/42123085/wicked-gladiator-ii-moana-2-could-break-thanksgiving-weekend-box-office-stocks-to-watch">The release of movies</a> like "Deadpool &amp; Wolverine," "Inside Out 2" and "Moana 2" on Disney+ could help boost subscriber growth ahead.
Crockett says DTC streaming is &#8220;the leading driver of segment profit growth in F2026.&#8221;
Price Action: Disney stock is down 0.58% to $112.41 on Monday versus a 52-week trading range of $83.91 to $123.74. Disney stock is up 24% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42422496/inside-out-2-deadpool-wolverine-baby-reindeer-dominate-entertainment-searches-on-google-in-2024-top-10-movies-tv-shows-and-more">&#8216;Inside Out 2,&#8217; &#8216;Deadpool &amp; Wolverine,&#8217; &#8216;Baby Reindeer&#8217; Google&#8217;s Top 2024 Entertainment Searches</a></li>
</ul>
Image: Shutterstock

Analyst Color

Entertainment

Price Target

Reiteration

Analyst Ratings

Trading Ideas

Disney Analyst Highlights Streaming, Theme Parks And 'Portfolio Durability'

Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) will conduct an investor call on Tuesday to provide full-year 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42415564/pfizer-invites-public-to-view-and-listen-to-webcast-of-december-17-conference-call-with-analysts-t" rel="noreferrer noopener">financial guidance</a>.
Ahead of the call, Goldman Sachs has outlined its expectations for the guide and commentary on the upcoming year.
The analyst anticipates that Pfizer&#8217;s management will guide to EPS in the mid-to-high $2 range with core business growth offset by the $0.30 in favorable but non-recurring items during 2024.
Pfizer highlighted several factors affecting its 2024 EPS that won&#8217;t carry over to 2025.
The 2024 EPS includes one-time boosts: a $1.2 billion benefit <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41596761/pfizer-q3-earnings-revenue-and-profit-on-heightened-demand-for-paxlovid-expects-10-billion-in-202" rel="noreferrer noopener">from Paxlovid stockpiling</a> and a U.S. government true-up and equity income from its stake in Haleon Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLN#NYSE">HLN</a>). However, Haleon income will not appear in 2025, as Pfizer&#8217;s ownership in Haleon is <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41112790/pfizer-divests-3-3b-stake-in-sensodyne-toothpaste-and-panadol-painkiller-maker-haleon" rel="noreferrer noopener">dropping below 20%</a>.
Goldman forecasts for 2025 revenues of $64.9 billion and EPS of $3.13, which compares to consensus estimates of $63.2 billion and $2.89, respectively.
Goldman Sachs notes that the impact of the IRA Part D redesign will likely be addressed in the company&#8217;s 2025 guidance. However, the analyst does not expect the details to be broken down by individual products but instead based on the overall commercial portfolio.
The analyst expects Paxlovid sales of $4.3 billion vs. consensus of $3.7 billion, though slightly more conservative on Vyndaqel sales of $5.9 billion vs. consensus of $6.2 billion.
Year-to-date, Eliquis has performed well, showing 12% growth thanks to market expansion and increased market share. This growth has been supported by Pfizer&#8217;s commercial team and boosted by Part D catastrophic coverage in 2024.
Looking ahead to 2025, Pfizer expects continued growth opportunities driven by market expansion and the potential for further share gains.
&#8220;We highlight dynamics across key topics and frame potential points of discussion with potential read-across beyond Pfizer specifically, noting that they are the only large cap pharma company in our coverage that we expect to opine on 2025 ahead of the new year,&#8221; Goldman analyst writes.
Price Action: PFE stock is down 0.39% at $25.48 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42507348/ozempic-maker-novo-nordisk-invests-over-1-billion-in-new-production-facility-in-denmark-comes-closer-to-add-three-more-from-catalent" target="_blank" rel="noreferrer noopener">Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent</a></li>
</ul>
Photo via Shutterstock.

Biotech

Earnings

Equities

Large Cap

Guidance

Health Care

General

What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?

JMP Securities initiated coverage on Addus HomeCare Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>), a provider of home-based personal care and clinical services.
JMP analysts see Addus HomeCare as having a uniquely strong and well-established presence in personal care services across multiple states, thanks to the company's scale and experienced management team.
The analyst writes that personal care is a cost-effective way to provide home-based services, especially as the U.S. faces a shortage of expensive skilled clinicians.
This approach also helps delay the need for more costly care options. With the highly fragmented personal care sector, Addus has opportunities to expand by adding complementary home health and hospice services to its existing markets.
The analysts expect this strategy to support sustained double-digit revenue growth for the company in the coming years.
In the third quarter, Addus HomeCare revenues were $289.8 million for the third quarter of 2024, a 7.0% increase compared with $270.7 million for <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41727154/addus-homecare-announces-third-quarter-2024-financial-results" rel="noreferrer noopener">the third quarter of 2023</a>.
JMP has initiated with a price target of $150, with <a target="_blank" href="https://www.benzinga.com/quote/ADUS/analyst-ratings" rel="noreferrer noopener">a Market Perform rating</a>.
Addus HomeCare recently acquired Gentiva's PC operations. The deal, the largest acquisition in the company's history, is expected to allow Addus HomeCare to enter Texas with critical mass and add personal care services in six other states, three of which are <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42276478/addus-homecare-completes-acquisition-of-personal-care-operations-of-gentiva" rel="noreferrer noopener">new to the company</a>.
Gentiva's PC platform is expected to contribute annual revenue of $275 million-$280 million, prompting 29% year-over-year personal care growth for Addus HomeCare in 2025, above the segment's five-year CAGR (2019-2024E) of 8%.
JMP writes that in recent years, Addus HomeCare has expanded into value-based care (VBC) arrangements in select markets through its "Care Advantage" program.
The company is well-positioned to grow in this area thanks to its combination of clinical and non-clinical care resources, along with its large-scale operations and robust case management systems.
Price Action: ADUS stock is up 5.14% at $131.42 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/24/12/42505835/honeywell-advances-strategic-review-explores-aerospace-business-separation" target="_blank" rel="noreferrer noopener">Honeywell Advances Strategic Review, Explores Aerospace Business Separation</a></li>
</ul>
Photo via Shutterstock

Initiation

Movers

ADUS

As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst

<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1200" height="711" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16185231/image-7.png" alt="" class="wp-image-4139" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16185231/image-7.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16185231/image-7-300x178.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16185231/image-7-1024x607.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16185231/image-7-768x455.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">Small Language Model</h4>
An enlarged chart of Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of MSFT stock is being used to illustrate the point.</li>
<li>The chart shows MSFT stock has climbed in December so far.</li>
<li>The chart shows support and resistance zones for MSFT.</li>
<li>RSI on the chart shows MSFT stock is overbought.&nbsp; Overbought stocks are susceptible to a pullback.</li>
<li>The Arora Report previously shared with readers a major milestone in AI progress – human-like reasoning capabilities using chain link thinking in Model 4o from OpenAI.</li>
<li>ChatGPT-4o is a large language model.</li>
<li>In further AI progress, Microsoft has introduced Phi-4.&nbsp; Phi-4 is a small language model that outperforms GPT-4o in certain mathematical reasoning.&nbsp; Phi-4 is only a fraction of the size of GPT-4o.&nbsp; It appears that Phi-4 can do better in solving certain math problems compared to its teacher model GPT-4o.&nbsp; Also of note is that Microsoft trained Phi-4 mostly on synthetic data.</li>
<li>The foregoing is important for investors as investors need to get ahead of the curve.&nbsp; In The Arora Report analysis, Phi-4 challenges the present belief that bigger is better.</li>
<li>In The Arora Report analysis, small language models such as Phi-4 have a very bright future.&nbsp; There is a fortune to be made in AI between now and 2030.&nbsp; However, it will not be in a straight line.&nbsp; At times, it will be treacherous.</li>
<li>There is excitement in the stock market this morning as it was announced Friday after the close that AI software company Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) and big bitcoin holder MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) are being added to the Nasdaq 100.</li>
<li>The Arora Report has previously written that one of the things Trump can do to reduce inflation from his policies is to attract foreign investment to the U.S.&nbsp; In the first sign of success for Trump, Japan's SoftBank Group Corp &#8211; ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) CEO Masayoshi Son will announce at Mar-a-Largo a $100B investment in the U.S. over the next four years.</li>
<li>There is also buying in the early trade as the market believes it is a certainty that the Fed will cut interest rates this week in spite of the data not supporting such a rate cut.</li>
<li>Markets in the U.S. are not being impacted by weakness in Europe and Asia as there was powerful pumping of stocks in the media over the weekend.&nbsp; Retail investors tend to be influenced by the weekend pump and buy on Monday morning.</li>
</ul>
<h4 class="wp-block-heading">France</h4>
Moody's has cut France's credit rating.&nbsp; French stocks and bonds are falling.
<h4 class="wp-block-heading">China</h4>
Markets all across the globe are being negatively impacted by weak retail sales data in China.
Retail sales in China came at 3.0% year-over-year vs 4.8% consensus.
Concern is building that the Chinese consumer is not spending in spite of stimulus measures by the government.
In The Arora Report analysis, investors should note the sharp contrast between U.S. consumers and Chinese consumers at this time.&nbsp; U.S. consumers are on a buying binge.&nbsp; Chinese consumers are holding back and are focused on savings.
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Amazon.com, Inc., Alphabet Inc Class C , Meta Platforms Inc , NVIDIA Corp , and Tesla Inc.
In the early trade, money flows are neutral in Apple Inc and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.&nbsp; Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.&nbsp; The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).&nbsp; The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).&nbsp; The most popular ETF for oil is United States Oil ETF (ASCA:USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Over the weekend, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ran over $106,000 on a rumor that Trump will announce the bitcoin reserve on day 1.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.&nbsp; The proprietary protection band from The Arora Report is very popular.&nbsp; The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider holding Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

$BTC

MSFT

MSTR

PLTR

SFTBY

AI Progress From Microsoft – Phi-4 Outperforms Human-like reasoner AI Model GPT-4o, Bitcoin Rumor

Tech stocks extended their rally to new heights on Monday, with the Nasdaq 100 index climbing over 1% to surpass 22,000 points, fueled by robust gains among key <a href="https://www.benzinga.com/tech">components in the index.</a>
Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) led the charge, soaring over 8% after receiving bullish price-target updates from analysts. The company's AI-driven growth potential gained further traction on Friday following its announcement of a collaboration with Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) to produce a cutting-edge AI chip.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) also rallied, jumping more than 5%, pushing its post-election gains to 85%, buoyed by positive analyst sentiment. Wedbush Securities described Tesla as a &#8220;game-changer&#8221; in AI and autonomous advancements under Trump's administration, adding to the bullish outlook.
Among other indices, the Russell 2000 rose 1%, while the S&amp;P 500 edged up 0.4%. The Dow Jones Industrial Average, however, dipped 0.2%, weighed down by losses in the energy and healthcare sectors.
On the economic front, private-sector surveys showed a stronger-than-expected rebound in December activity. The services sector Purchasing Managers&#8217; Index (PMI) surged to 58.5, the highest reading since October 2021. Meanwhile, the Composite PMI climbed to 56.6, its best level since April 2022, as robust growth in services offset continued weakness in manufacturing.
Crypto-related assets gained fresh bullish momentum, driven by speculation about the U.S. government creating a Bitcoin Strategic Reserve fund. Meanwhile, MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) will be added to the Nasdaq 100 Index on Dec. 23, further boosting sentiment.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reached $107,000, marking a year-to-date gain of 153%. MicroStrategy shares rose 5.8%, while other crypto-linked stocks, such as MARA Digital Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), Riot Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>), and Coinbase Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), surged 11.1%, 9.2%, and 4.5%, respectively.
<h3 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1-day %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>22,043.82</td>
<td>1.2%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,369.39</td>
<td>1.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,076.94</td>
<td>0.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,750.42</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:15 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121624&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $607.34.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 0.2% to $438.86.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 1.4% to $537.94.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 1% to $235.13.</li>
<li>The&nbsp;Consumer Discretionary Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up by 1.2%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.8%.</li>
</ul>
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
<ul>
<li>Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) rose 7.1%, reflecting bullish investor sentiment ahead of its earnings report on Wednesday after the close.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) rose by 4.7%, building up momentum after last week&#8217;s 8.7% surge following the announcement of the quantum computer launch. </li>
<li>Shares of of natural gas companies fell amid prospects for less colder weather in the upcoming weeks. New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) led industry declines, down 7%. </li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42514008/fed-poised-to-cut-interest-rates-by-0-25-this-week-heres-why-your-focus-should-shift-to-other-signals">Fed Poised To Cut Interest Rates By 0.25% This Week: Here&#8217;s Why Your Focus Should Shift To Other Signals</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Small Cap

Econ #s

Economics

Tech

ETFs

AAPL

AVGO

COIN

SPDR Dow Jones Industrial Average ETF Trust

GOOGL

MARA

RIOT

TSLA

Select Sector SPDR-Consumer Discretionary

Broadcom, Tesla Propel Nasdaq 100 Gains, Bitcoin Hits $107,000, Fueling Crypto Stocks Rally: What's Driving Markets Monday?

WIIM

CRWD

Crowdstrike shares are trading higher. JP Morgan maintained its Overweight rating on the stock and raised its price target from $372 to $418.

Investors with a lot of money to spend have taken a bearish stance on AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AVAV, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for AeroVironment.
This isn't normal.
The overall sentiment of these big-money traders is split between 21% bullish and 42%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $246,086, and 10 are calls, for a total amount of $620,396.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $105.0 and $185.0 for AeroVironment, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of AeroVironment stands at 97.25, with a total volume reaching 519.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AeroVironment, situated within the strike price corridor from $105.0 to $185.0, throughout the last 30 days.
<h3>AeroVironment Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734374730_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$64.6</td>
<td>$60.9</td>
<td>$62.78</td>
<td>$105.00</td>
<td>$162.7K</td>
<td align="right">0</td>
<td align="right">26</td>
</tr>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$62.4</td>
<td>$58.8</td>
<td>$60.59</td>
<td>$105.00</td>
<td>$157.0K</td>
<td align="right">50</td>
<td align="right">26</td>
</tr>
<tr>
<td>AVAV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$8.2</td>
<td>$8.2</td>
<td>$165.00</td>
<td>$106.7K</td>
<td align="right">143</td>
<td align="right">130</td>
</tr>
<tr>
<td>AVAV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$26.7</td>
<td>$26.6</td>
<td>$26.6</td>
<td>$185.00</td>
<td>$79.8K</td>
<td align="right">139</td>
<td align="right">51</td>
</tr>
<tr>
<td>AVAV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$12.3</td>
<td>$12.0</td>
<td>$12.01</td>
<td>$160.00</td>
<td>$50.9K</td>
<td align="right">168</td>
<td align="right">84</td>
</tr>
</tbody>
</table>

<h3>About AeroVironment</h3>
AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky.
<h3>Where Is AeroVironment Standing Right Now?</h3>
<ul>
<li>With a trading volume of 655,958, the price of AVAV is up by 1.92%, reaching $159.5.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 77 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for AeroVironment</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $230.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Jefferies has elevated its stance to Buy, setting a new price target at $230. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AeroVironment options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

AVAV

What the Options Market Tells Us About AeroVironment

Whales with a lot of money to spend have taken a noticeably bullish stance on Newmont.
Looking at options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $437,295 and 14, calls, for a total amount of $1,356,261.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $30.0 to $55.0 for Newmont over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Newmont stands at 3573.42, with a total volume reaching 18,285.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Newmont, situated within the strike price corridor from $30.0 to $55.0, throughout the last 30 days.
<h3>Newmont 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734374725_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.42</td>
<td>$2.29</td>
<td>$2.39</td>
<td>$45.00</td>
<td>$358.5K</td>
<td>2.7K</td>
<td>1.5K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.2</td>
<td>$6.1</td>
<td>$6.1</td>
<td>$35.00</td>
<td>$244.2K</td>
<td>631</td>
<td>400</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.25</td>
<td>$1.24</td>
<td>$1.25</td>
<td>$45.00</td>
<td>$237.0K</td>
<td>11.3K</td>
<td>2.2K</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$0.91</td>
<td>$0.9</td>
<td>$0.9</td>
<td>$35.00</td>
<td>$144.0K</td>
<td>6.7K</td>
<td>1.6K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$45.00</td>
<td>$115.1K</td>
<td>319</td>
<td>300</td>
</tr>
</tbody>
</table>

<h3>About Newmont</h3>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
Following our analysis of the options activities associated with Newmont, we pivot to a closer look at the company's own performance.
<h3>Current Position of Newmont</h3>
<ul>
<li>With a trading volume of 4,814,346, the price of NEM is down by -0.29%, reaching $40.1.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 66 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Newmont, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Market Whales and Their Recent Bets on NEM Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Constellation Energy.
Looking at options history for Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 80% of the investors opened trades with bullish expectations and 10% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $475,500 and 4, calls, for a total amount of $284,500.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $250.0 for Constellation Energy, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Constellation Energy stands at 1269.86, with a total volume reaching 1,205.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Constellation Energy, situated within the strike price corridor from $200.0 to $250.0, throughout the last 30 days.
<h3>Constellation Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734374720_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CEG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$16.7</td>
<td>$16.0</td>
<td>$16.75</td>
<td>$250.00</td>
<td>$190.8K</td>
<td align="right">816</td>
<td align="right">146</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$55.9</td>
<td>$54.6</td>
<td>$54.6</td>
<td>$200.00</td>
<td>$136.5K</td>
<td align="right">76</td>
<td align="right">25</td>
</tr>
<tr>
<td>CEG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$30.4</td>
<td>$28.8</td>
<td>$28.8</td>
<td>$220.00</td>
<td>$100.8K</td>
<td align="right">152</td>
<td align="right">35</td>
</tr>
<tr>
<td>CEG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$12.9</td>
<td>$12.3</td>
<td>$12.4</td>
<td>$220.00</td>
<td>$62.0K</td>
<td align="right">143</td>
<td align="right">50</td>
</tr>
<tr>
<td>CEG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.9</td>
<td>$15.1</td>
<td>$15.1</td>
<td>$210.00</td>
<td>$60.4K</td>
<td align="right">134</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Constellation Energy</h3>
Constellation Energy Corp offers energy solutions. It provides clean energy and sustainable solutions to homes, businesses, the public sector, community aggregations, and a range of wholesale customers (such as municipalities, cooperatives, and other strategics). The company offers comprehensive energy solutions and a variety of pricing options for electric, natural gas, and renewable energy products for companies of any size.
<h3>Current Position of Constellation Energy</h3>
<ul>
<li>Trading volume stands at 963,178, with CEG's price up by 0.84%, positioned at $241.08.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 71 days.</li>
</ul>
<h3>What The Experts Say On Constellation Energy</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $295.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Constellation Energy, which currently sits at a price target of $322. 
&#x2A; In a positive move, an analyst from B of A Securities has upgraded their rating to Buy and adjusted the price target to $269. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Constellation Energy options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Check Out What Whales Are Doing With CEG

On Friday, Nasdaq Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) annual reconstitution of the Nasdaq-100 Index will become effective before the market <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42494812/annual-changes-to-the-nasdaq-100-index" rel="noreferrer noopener">opens on December 23</a>.
Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) was&nbsp;removed&nbsp;<a target="_blank" href="https://www.benzinga.com/24/12/42495649/microstrategy-palantir-axon-added-to-nasdaq-100-super-micro-computer-moderna-illumina-exit-the-index" rel="noreferrer noopener">from the index</a>. Year to date, the stock has increased around 8%, underperforming iShares Core S&amp;P Mid-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IJH#NYSE">IJH</a>).
The provider of DNA sequencing and array-based technologies has been in the news due to its controversial multi-billion dollar deal to acquire cancer test maker Grail Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/m-a/24/09/40688420/european-court-rules-in-favor-of-illumina-in-fight-against-probe-into-grail-deal-asks-not-to-pay-478" rel="noreferrer noopener">European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine</a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16125312/newplot-2-1.png" alt="" class="wp-image-694387" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16125312/newplot-2-1.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16125312/newplot-2-1-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Nearly four years after pitching for&nbsp;Grail,&nbsp;Illumina finally separated the&nbsp;<a target="_blank" href="https://www.benzinga.com/m-a/24/09/40688420/european-court-rules-in-favor-of-illumina-in-fight-against-probe-into-grail-deal-asks-not-to-pay-478" rel="noreferrer noopener">cancer blood test developer</a>.&nbsp;To expand its reach in single-cell analysis and&nbsp;multiomics research, Illumina <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39714633/illumina-buys-fluent-biosciences-to-gain-stronger-foothold-in-single-cell-analysis" rel="noreferrer noopener">acquired privately-held</a> Fluent BioSciences.
Also in March, activist investor&nbsp;Carl Icahn opted against pursuing a fresh challenge to Illumina&#8217;s board, which spares the U.S. gene sequencing company from facing its second proxy battle in consecutive years.&nbsp;
Previously, Icahn had expressed intentions to remove additional directors from Illumina&#8217;s board, attributing the company&#8217;s substantial market value decline and the ill-fated $7.1 billion Grail acquisition to mismanagement by the <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37671511/gene-sequencing-firm-illumina-escapes-carl-icahns-second-proxy-battle-amid-grail-divestment-effort" rel="noreferrer noopener">existing board members</a>.&nbsp;
Most recently, Illumina reported third-quarter&nbsp;adjusted EPS of $1.14, beating the consensus of $0.88, with sales&nbsp;of $1.08 billion, almost in line with the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41727185/illumina-reports-financial-results-for-third-quarter-of-fiscal-year-2024" rel="noreferrer noopener">consensus of $1.08 billion</a>.
&#8220;During the third quarter, the Illumina team delivered strong operating results, and revenue met our expectations,&#8221; said&nbsp;Jacob Thaysen, Chief Executive Officer.
&#8220;The near-term macroeconomic environment remains constrained, and we are slightly lowering our 2024 revenue guidance,&#8221; Thaysen added.
Price Action: ILMN stock is down 0.12% at $143.70 at the last check on Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42514376/whats-going-on-moderna-stock-on-monday" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Moderna Stock On Monday?</a></li>
</ul>
Photo via Shutterstock

GRAL

ILMN

NDAQ

What's Going On With Illumina Stock On Monday?

On Friday, Nasdaq Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42494812/annual-changes-to-the-nasdaq-100-index" rel="noreferrer noopener">on December 23</a>.
As a result, Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) was&nbsp;removed&nbsp;<a target="_blank" href="https://www.benzinga.com/24/12/42495649/microstrategy-palantir-axon-added-to-nasdaq-100-super-micro-computer-moderna-illumina-exit-the-index" rel="noreferrer noopener">from the index</a>. Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
Recently, Moderna and several other stocks witnessed a decline as Robert F. Kennedy Jr.'s, Donald Trump's nomination to lead the&nbsp;Department of&nbsp;Health and Human Services, is known to be against vaccines and has a track record of making false <a target="_blank" href="https://www.benzinga.com/24/11/42045488/moderna-remains-confident-despite-political-concerns-over-vaccine-safety-and-hhs-nomination" rel="noreferrer noopener">claims about vaccines</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42045488/moderna-remains-confident-despite-political-concerns-over-vaccine-safety-and-hhs-nomination" rel="noreferrer noopener">Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination</a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16123322/newplot-1-3.png" alt="" class="wp-image-694341" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16123322/newplot-1-3.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16123322/newplot-1-3-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
The company has witnessed a decline in its only approved product, Spikevax, <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40104375/moderna-stock-sinks-on-lowered-2024-outlook-cites-low-european-sales-competitive-rsv-vaccine-mark" rel="noreferrer noopener">the COVID-19 vaccine</a>.
However, Moderna witnessed some relief on higher third-quarter sales attributed to higher sales in the U.S. market following the earlier launch of the <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41854205/modernas-q3-earnings-beat-overshadowed-by-vaccine-demand-slowdown-and-market-share-concerns-analysts-warn" rel="noreferrer noopener">updated COVID-19 vaccine</a>.
Moderna&nbsp;unveiled key updates at its annual R&amp;D Day in September, spotlighting its mRNA-based pipeline and <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40834547/moderna-outlines-post-covid-roadmap-cuts-research-budget-forecasts-2025-sales-below-expectations" rel="noreferrer noopener">revised financial plans</a>.
Faced with commercial challenges, Moderna is adopting a more selective approach to R&amp;D investments. The company anticipates maintaining substantial R&amp;D investment, especially in oncology and rare diseases, while pacing other expenditures.
Moderna is also facing several litigations, including the recently announced patent infringement lawsuit filed by Northwestern University. The lawsuit alleges that the pharmaceutical company used the university's lipid nanoparticle (LNP) technology without permission to develop&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41381861/moderna-hit-with-another-lawsuit-related-to-key-covid-19-vaccine-technology" rel="noreferrer noopener">its COVID-19 vaccines.</a>
GSK Plc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) also filed a lawsuit alleging that Moderna's mRNA vaccines infringe on&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41342286/gsk-sues-moderna-alleging-mrna-vaccine-patent-infringement" rel="noreferrer noopener">patents it developed</a>.
Price Action: MRNA stock is down 1.04% at $41.40 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42507816/taiwan-semiconductor-ceo-highlights-ai-powered-drones-next-gen-robots-as-growth-drivers" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor CEO Highlights AI-Powered Drones, Next-Gen Robots As Growth Drivers</a></li>
</ul>
Photo via <a href="https://commons.wikimedia.org/wiki/File:Moderna_COVID-19_vaccine_%282021%29_F.jpg">Wikimedia Commons</a>

MRNA

What's Going On With Moderna Stock On Monday?

QBTS

D-Wave Quantum shares are trading higher. Shares of quantum-related stocks are trading higher amid continued momentum in the sector.

Keysight Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) shares are trading higher on Monday after JP Morgan analyst Samik Chatterjee upgraded the company to Overweight from Neutral&nbsp;and <a target="_blank" href="https://www.benzinga.com/quote/KEYS/analyst-ratings" rel="noreferrer noopener">raised the price target to $200 from $170</a>.
The analyst&#8217; bullish stance reflects expectations of broadening demand drivers and a cyclical recovery in end-markets through 2025.
After facing challenges in 2024, including higher capital costs, slower industry growth, and inventory digestion, the analyst sees recovery driven by the Spirent acquisition.
Chatterjee says that this will enhance Keysight&#8217;s leverage in cyclical markets and improve margins through operational synergies, moving toward a long-term target of 31% &#8211; 32% operating margins.
With earnings revisions showing upside after recent downward pressures, the analyst expects Keysight to return to premium valuation multiples, reflecting management&#8217;s strong track record and high-quality earnings with significant leverage on modest revenue gains.
The analyst raised FY25 organic growth forecasts, anticipating stronger revenue growth, especially in the second half, and factoring in Spirent&#8217;s contribution. This leads to a forecast of 12% EPS growth in FY25 and 17% in FY26.
Chatterjee expects demand drivers to broaden beyond the current focus on AI as the company transitions from FY24 to FY25.
With lower interest rates and capital costs, the analyst anticipates increased customer spending, particularly from traditionally cautious sectors, adds the analyst.
The analyst says that includes stronger demand from telecom customers, growth in semiconductor capital spending, and potential improvements in consumer and industrial demand.
This will benefit R&amp;D and production test demand from a wider range of customers, including smartphone chipset suppliers and industrial technology companies, adds the analyst.
The analyst writes that Keysight is positioned to benefit from a more favorable industry environment compared to the challenges faced in FY24.
Investors can gain exposure to the stock via VictoryShares THB Mid Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDCP#NASDAQ">MDCP</a>)&nbsp;and American Century Mid Cap Growth Impact ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MID#NYSE">MID</a>).
Price Action: KEYS shares are up 3.14% at $171.73 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42513221" target="_blank" rel="noreferrer noopener">Capri Holdings Stock Climbs On Report Of Potential Sale Of Versace, Jimmy Choo</a></li>
</ul>

Upgrades

KEYS

MDCP

Keysight's Spirent Acquisition And Cyclical Recovery To Drive 12% EPS Growth In FY25; JP Morgan Upgrades Stock

FTX on Monday announced that its<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42151412/bankrupt-crypto-exchange-ftx-to-commence-payments-to-customers-creditors-in-early-2025"> Chapter 11 bankruptcy reorganization plan</a> will become effective on Jan. 3, 2025.
Customer and creditor distributions will be facilitated through partnerships with cryptocurrency platforms Kraken and BitGo.
The first round of distributions is expected to occur within 60 days of the plan's effective date.
The initial distribution will cover holders of allowed claims in the Convenience Classes, while timelines for other claim classes will be announced later, <a href="https://www.prnewswire.com/news-releases/ftx-announces-effective-date-and-record-date-of-january-3-2025-for-its-chapter-11-plan-of-reorganization-302332816.html">according</a> to a press release.
Customers and creditors eligible for distributions must complete several steps, including logging into the FTX Customer Portal, completing Know Your Customer (KYC) verification, submitting necessary tax forms, and onboarding with Kraken or BitGo. 
Detailed onboarding instructions will be provided through the portal.
FTX CEO John J. Ray III highlighted the significance of these developments, saying, "The Plan becoming effective in January 2025 and the start of distributions are reflections of the outstanding success of the recovery efforts." 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42512673/ai-cryptocurrencies-surge-208-to-61-5-billion-market-cap-in-2024-these-were-the-top-performers">AI Cryptocurrencies Surge 208% To $61.5 Billion Market Cap In 2024: These Were The Top Performers</a>
He added that meticulous work over the past two years has helped recover billions of dollars, positioning the company to begin returning funds to customers and creditors.
Kraken and BitGo will handle the distribution of recovered funds across supported jurisdictions. 
FTX noted that additional service providers may be announced in the future through its Customer Portal and official communication channels.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42509614/microstrategy-expands-bitcoin-holdings-by-15350-btc-worth-15-billion-after-joining-nasdaq-100">MicroStrategy Expands Bitcoin Holdings By 15,350 BTC Worth $1.5 Billion After Joining Nasdaq 100</a></li>
</ul>
Image: Shutterstock

FTX Reorganization Plan Set For January 3, Distributions To Commence Within 60 Days

Canaccord Genuity analyst Matthew Lee maintains Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>) with a Buy and raises the price target from C$87 to C$89.

TSX:TD

Canaccord Genuity Maintains Buy on Toronto-Dominion Bank, Raises Price Target to C$89

Whales with a lot of money to spend have taken a noticeably bearish stance on GE Vernova.
Looking at options history for GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $170,585 and 15, calls, for a total amount of $677,995.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $200.0 to $360.0 for GE Vernova over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for GE Vernova's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of GE Vernova's whale trades within a strike price range from $200.0 to $360.0 in the last 30 days. 
<h3>GE Vernova 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734373830_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$16.8</td>
<td>$14.3</td>
<td>$15.5</td>
<td>$330.00</td>
<td>$96.1K</td>
<td>375</td>
<td align="right">63</td>
</tr>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.9</td>
<td>$1.7</td>
<td>$1.9</td>
<td>$280.00</td>
<td>$74.4K</td>
<td>477</td>
<td align="right">441</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.7</td>
<td>$11.7</td>
<td>$11.7</td>
<td>$350.00</td>
<td>$73.7K</td>
<td>692</td>
<td align="right">86</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$74.9</td>
<td>$73.3</td>
<td>$73.3</td>
<td>$330.00</td>
<td>$73.3K</td>
<td>18</td>
<td align="right">10</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$44.6</td>
<td>$42.5</td>
<td>$43.31</td>
<td>$300.00</td>
<td>$69.1K</td>
<td>2.2K</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About GE Vernova</h3>
GE Vernova is a global leader in the electric power industry, with products and services that generate, transfer, convert, and store electricity. The company has three business segments: power, wind, and electrification. Power includes gas, nuclear, hydroelectric, and steam technologies, providing dispatchable power. The wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. Electrification includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, and storage of electricity from the point of generation to point of consumption.
After a thorough review of the options trading surrounding GE Vernova, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is GE Vernova Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 936,245, the GEV's price is up by 1.09%, now at $335.63. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 11 days.</li>
</ul>
<h3>Expert Opinions on GE Vernova</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $404.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Guggenheim persists with their Buy rating on GE Vernova, maintaining a target price of $400. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on GE Vernova with a target price of $420. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on GE Vernova, maintaining a target price of $400. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on GE Vernova, maintaining a target price of $411. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for GE Vernova, targeting a price of $391. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest GE Vernova options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

GE Vernova Unusual Options Activity For December 16

Deep-pocketed investors have adopted a bearish approach towards Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in EOSE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for Eos Energy Enterprises. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 39% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $51,448, and 26 are calls, amounting to $1,479,511.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $1.0 to $5.5 for Eos Energy Enterprises during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eos Energy Enterprises's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eos Energy Enterprises's substantial trades, within a strike price spectrum from $1.0 to $5.5 over the preceding 30 days.
<h3>Eos Energy Enterprises Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734373824_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$1.63</td>
<td>$1.5</td>
<td>$1.5</td>
<td>$2.50</td>
<td>$150.0K</td>
<td>2.5K</td>
<td>1.0K</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.16</td>
<td>$1.1</td>
<td>$1.16</td>
<td>$5.00</td>
<td>$147.7K</td>
<td>27.8K</td>
<td>1.3K</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$2.15</td>
<td>$2.14</td>
<td>$2.15</td>
<td>$3.00</td>
<td>$122.9K</td>
<td>4.0K</td>
<td>608</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.36</td>
<td>$1.15</td>
<td>$1.2</td>
<td>$5.00</td>
<td>$72.2K</td>
<td>27.8K</td>
<td>2.3K</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.5</td>
<td>$1.34</td>
<td>$1.5</td>
<td>$2.50</td>
<td>$70.0K</td>
<td>2.5K</td>
<td>1.6K</td>
</tr>
</tbody>
</table>

<h3>About Eos Energy Enterprises</h3>
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial &amp; industrial (C&amp;I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
Having examined the options trading patterns of Eos Energy Enterprises, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Eos Energy Enterprises</h3>
<ul>
<li>Trading volume stands at 13,433,925, with EOSE's price up by 18.38%, positioned at $4.03.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 77 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eos Energy Enterprises, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

EOSE

Eos Energy Enterprises Options Trading: A Deep Dive into Market Sentiment

Whales with a lot of money to spend have taken a noticeably bearish stance on Barrick Gold.
Looking at options history for Barrick Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) we detected 27 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 48% with bearish.
From the overall spotted trades, 12 are puts, for a total amount of $413,334 and 15, calls, for a total amount of $1,131,839.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $8.0 to $20.0 for Barrick Gold over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Barrick Gold's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Barrick Gold's significant trades, within a strike price range of $8.0 to $20.0, over the past month.
<h3>Barrick Gold Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734373816_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.39</td>
<td>$1.25</td>
<td>$1.28</td>
<td>$20.00</td>
<td>$139.3K</td>
<td>83.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$1.39</td>
<td>$1.3</td>
<td>$1.35</td>
<td>$20.00</td>
<td>$135.0K</td>
<td>83.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.39</td>
<td>$1.3</td>
<td>$1.3</td>
<td>$20.00</td>
<td>$130.9K</td>
<td>83.4K</td>
<td>2.0K</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.34</td>
<td>$1.28</td>
<td>$1.3</td>
<td>$20.00</td>
<td>$130.0K</td>
<td>83.4K</td>
<td>5.1K</td>
</tr>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.35</td>
<td>$1.28</td>
<td>$1.3</td>
<td>$20.00</td>
<td>$130.0K</td>
<td>83.4K</td>
<td>4.0K</td>
</tr>
</tbody>
</table>

<h3>About Barrick Gold</h3>
Based in Toronto, Barrick Gold is one of the world's largest gold miners. In 2023, the firm produced nearly 4.1 million attributable ounces of gold and about 420 million pounds of copper. At year-end 2023, Barrick had about two decades of gold reserves along with significant copper reserves. After buying Randgold in 2019 and combining its Nevada mines in a joint venture with competitor Newmont later that year, it operates mines in 19 countries in the Americas, Africa, the Middle East, and Asia. The company also has growing copper exposure. Its potential Reko Diq project in Pakistan, if developed, could double copper production by the end of the decade.
Following our analysis of the options activities associated with Barrick Gold, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Barrick Gold</h3>
<ul>
<li>Currently trading with a volume of 11,517,916, the GOLD's price is down by -1.67%, now at $16.5. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 58 days.</li>
</ul>
<h3>What Analysts Are Saying About Barrick Gold</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $24.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Raymond James persists with their Outperform rating on Barrick Gold, maintaining a target price of $25. 
&#x2A; An analyst from Scotiabank persists with their Sector Outperform rating on Barrick Gold, maintaining a target price of $23. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Barrick Gold with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

GOLD

Smart Money Is Betting Big In GOLD Options

MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) stock is trading higher on Monday, along with other crypto-linked stocks, after Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reached an <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42507864/bitcoin-etfs-surge-as-king-crypto-hits-106000">all time high.</a>
The Details: As of early Monday afternoon, Bitcoin is trading above $107,000, according to data from Benzinga Pro. MARA, heavily involved in Bitcoin mining, benefits from this surge.
Other Bitcoin miners, such as Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) and CleanSpark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>), also stand to benefit from Bitcoin&#8217;s gains.
What Else: In early December MARA completed its $850 million offering of zero-coupon convertible senior notes due 2031. The company anticipates about $835.1 million in net proceeds from this offering.
MARA plans to use about $48 million of the net proceeds from the sale of the notes to repurchase roughly $51 million of its existing convertible notes due 2026 in private transactions. The remaining proceeds will go toward acquiring additional bitcoin and general corporate purposes, including working capital, strategic acquisitions, asset expansion and debt repayment.
In addition, at the start of the month, the company signed a definitive agreement to acquire a wind farm in Hansford County, Texas, with 240 MW of interconnection capacity and 114 MW of nameplate wind capacity.&nbsp;
The company plans to build and operate a behind-the-meter data center powered entirely by the site's 114 MW of wind capacity at no additional energy cost. This is part of MARA&#8217;s strategy to transform underutilized sustainable resources into economic value, achieve near-zero energy costs and support the broader adoption of renewable energy.
Related Link: <a href="https://www.benzinga.com/analyst-ratings/price-target/24/12/42513306/elon-musks-tesla-nearly-5-times-more-expensive-than-industry-average-stock-surges-over-60-since-election">Elon Musk&#8217;s Tesla Nearly 5 Times More Expensive Than Industry Average: Stock Surges Over 60% Since Election</a>
MARA Price Action: At the time of publication, MARA shares are trading 11.5% higher at $25.34, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Eivind Pedersen from Pixabay

CLSK

What's Going On With MARA Shares Monday?

Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) is turning heads in the market with its recently formed <a href="https://www.benzinga.com/topic/golden-cross">a Golden Cross</a> — a bullish technical pattern where the 50-day moving average crosses above the 200-day moving average.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16124327/Screenshot-2024-12-16-at-11.06.05-PM.png" alt="" class="wp-image-694364" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16124327/Screenshot-2024-12-16-at-11.06.05-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16124327/Screenshot-2024-12-16-at-11.06.05-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121624&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
At $168.97, the stock price reflects strong momentum, sitting well above both the 50-day SMA (simple moving average) of $138.86 and the 200-day SMA of $138.20. 
The MACD (moving average convergence/divergence) indicator stands at a bullish 10.42, reinforcing the stock's upward trajectory.
However, short-term signals present a mixed bag. The eight-day SMA of $174.70 suggests some selling pressure, while the 20-day SMA at $167.46 aligns with a bullish signal, hinting at near-term consolidation. 
With an RSI (relative strength index) of 60.03, Snowflake stays in neutral territory, leaving room for further upward movement.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42171519/snowflake-elastic-poised-for-ai-revolution-gains-analyst-upgrades-the-stocks">Snowflake, Elastic Poised For AI Revolution Gains, Analyst Upgrades The Stocks</a>
<h2 class="wp-block-heading">Snowflake&#8217;s AI Advantage</h2>
Jefferies has raised its price target to $200, naming Snowflake a top <a href="https://www.benzinga.com/topic/artificial-intelligence">AI</a> pick for 2025, <a href="https://www.investing.com/news/analyst-ratings/snowflake-stock-a-top-ai-pick-for-2025-says-jefferies-ups-price-target-to-200-93CH-3773617">reported</a> Investing. The firm cites Snowflake's emphasis on AI product development as a key driver for future revenue and backlog growth. 
The company's strong fundamentals, including a 30.28% revenue growth rate and a 67.33% gross profit margin, underscore its potential.
<a href="https://www.benzinga.com/quote/SNOW/analyst-ratings">Other analysts are equally bullish</a>. KeyBanc recently set a $210 price target, and Citi raised its bar to $225, following what it called a "redemption quarter" for the company. 
Both firms highlight Snowflake's ability to capitalize on the surging demand for data and AI-driven solutions, aligning with the broader industry shift toward digital transformation.
<h2 class="wp-block-heading">Snowflake Poised For Long-Term Growth</h2>
With a Golden Cross signaling bullish momentum and Wall Street analysts stacking the deck in its favor, Snowflake appears poised for long-term growth. 
The fusion of strong technicals and AI-fueled optimism cements Snowflake's position as a leader in the evolving data landscape.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/24/12/42509206/soundhound-ai-soars-over-700-short-squeeze-potential-has-traders-talking">SoundHound AI Soars Over 700%: Short Squeeze Potential Has Traders Talking</a></li>
</ul>
Image: Shutterstock

Long Ideas

Signals

SNOW

Snowflake AI Revolution Gains Traction, Stock Forms Golden Cross

Nano-X Imaging (NNOX) has released an update. Nano-X Imaging's Nanox.ARC system has received FDA clearance for broader use, including pulmonary and...

Nano-X Imaging Expands FDA Clearance for Nanox.ARC

Nano-X Imaging (NNOX) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Nanox.ARC, a stationary X-...

Nano-X Imaging's Nanox.ARC imaging system receives FDA clearance

Unusual total active option classes on open include: Nano X (NNOX), Quantumscape (QS), Planet Labs PBC (PL), Okta (OKTA), Dollar General (DG), Defi...

Unusually active option classes on open December 5th

Nano-X gets expanded FDA clearance for Nanox.ARC

Bitcoin smashes $100K! Discover what this milestone means for crypto and risk assets, plus our Top 5 stock picks for the day analyzed through catalysts, sentiment, fundamentals, and technicals.

Crypto Surge Sparks Market Frenzy: Today's Must-Watch Picks

Cantor Fitzgerald raised the firm's price target on Nano-X Imaging (NNOX) to $12 from $11 and keeps an Overweight rating on the shares. After the c...

Nano-X Imaging price target raised to $12 from $11 at Cantor Fitzgerald

Nano-X Imaging: Expanded FDA Clearance Paves The Path For Deployment

Shares of the medical imaging company Nano-X Imaging ($NNOX) have been surging following a recent regulatory clearance from the U.S. Food and Drug ...

Nano-X Imaging's (NNOX) Shares Surge on FDA Approval but Have Yet to Reach Profitability

Latest data shows the largest indicative borrow rate increases among liquid option names include: VinFast Auto LTD (

Largest borrow rate increases among liquid names

Nano-X Imaging ( ($NNOX) ) has provided an announcement. Nano-X Imaging Ltd announced that during its Annual General Meeting of Shareholders, all p...

Nano-X Imaging Secures Shareholder Approval for Key Proposals

BLUE

GWAV

LPSN

MEOBF

MESO

MRVL

MSTX

OKTA

TLRY

TQQQ

WKHS

Press Releases

Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of Cardiovascular Computed Tomography

Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024

Nanox to Report Second Quarter and Financial Results on August 20, 2024

Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update

Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium

Comments

Nano X Imaging

Nano X Imaging (NNOX) 옵션

Nano X Imaging (NASDAQ:NNOX) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌